SCHEMBL25933822

SCHEMBL25933822

CC(C)(C)OC(=O)N1CCN(CCOc2ccc(C3CCN(c4ccc(C#N)c(C(F)(F)F)c4)CC3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AR P10275 17/20 0.47
BRD4 O60885 1/20 0.46
KCNH2 Q12809 1/20 0.46
RET P07949 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30493231 0.91 AR (0.45) ARBRD4KCNH2
SCHEMBL25929486 0.89 GPR119 (0.51) ARRET
SCHEMBL25934240 0.88 AR (0.49) ARRET
SCHEMBL25934165 0.88 AR (0.50) AR
SCHEMBL25437610 0.87 AR (0.46) AR
SCHEMBL25330426 0.87 AR (0.46) ARRET
SCHEMBL25330446 0.86 AR (0.43) ARRET
SCHEMBL30493235 0.86 AR (0.43) ARRET
SCHEMBL30493283 0.86 HRH2 (0.45) KCNH2RET
SCHEMBL30493264 0.85 GPR119 (0.48) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4466260-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2024-11-27 EP disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed